suzetrigine

News

Vertex bags FDA okay for its non-opioid pain drug

Vertex gets FDA approval for its non-opioid pain drug suzetrigine, the first new class of pain medicine in the US in more than 20 years.

News

Silhouette graphic of a main with spinal pain in the lumbar region

Vertex weakens after neuropathic pain trial reads out

A trial of Vertex's suzetrigine in neuropathic back pain met its primary objective, but shares in the company fell as investors reacted to the data.

News

Vertex eyes FDA decision on non-opioid pain drug in January

Vertex Pharma has filed for FDA approval of its non-opioid pain drug suzetrigine, starting the clock ticking on a review that should be completed early next year.

R&D

Non-opioid painkillers: Another tool to fight the opioid epi...

The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control.

Vertex bags FDA okay for its non-opioid pain drug

Vertex weakens after neuropathic pain trial reads out

Vertex eyes FDA decision on non-opioid pain drug in January

Non-opioid painkillers: Another tool to fight the opioid epi...

Merck rare tumour drug Ezmekly backed for NHS use

Discover a new era of healthcare panel engagement: Grounded ...

suzetrigine

Editor's Picks